Assaya was born to provide the world with reliable, augmented, practical and inexpensive diagnostics (RAPID) that can be deployed anywhere, anytime to identify biomarkers and dangerous pathogens in near real-time to prevent the spread of disease, in a sustainable and ethically responsible manner. We are acutely focused on delivering the capability to ensure todays and tomorrows pathogens are accurately identified, measured and reported upon in the shortest possible time frame, at the lowest possible price, with the least possible infrastructure investment, on a global scale, in both clinical and non-clinical environments.